The introduction of ART medicines has dramatically changed the prognosis of HIV infected patients and contributed to ease the burden of disease of patients, the patients´ families and societies.
Recent pandemic threats caused by new and old virus infections have emphasized the urgent need to develop drugs that not only target the life cycle of the virus but also boost the immune system...
According to www.clinicaltrials.gov there are more than 7 000 clinical trials that investigate various aspects of HIV infected patients including investigational research...
